Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma.
Journal article
Carroll TM. et al, (2023), Cancer cell, 41, 1222 - 1241.e7
Disparities in care and outcomes for primary liver cancer in England during 2008-2018: a cohort study of 8.52 million primary care population using the QResearch database.
Journal article
Liao W. et al, (2023), EClinicalMedicine, 59
Association between epigenetic heterogeneity of esophageal adenocarcinoma and response to first-line immunochemotherapy in LUD2015-005 Trial
Conference paper
Xie PF. et al, (2023), CANCER RESEARCH, 83
Characterisation of the genetic determinants of context specific DNA methylation in primary monocytes
Preprint
Gilchrist J. et al, (2023)
Comprehensive molecular profiling to predict first-line immunochemotherapy outcomes in inoperable esophageal adenocarcinoma
Conference paper
Carroll TM. et al, (2022), CANCER RESEARCH, 82
Author Correction: The effects of mutational processes and selection on driver mutations across cancer types.
Other
Temko D. et al, (2020), Nature communications, 11
Bisulfite-free, Base-resolution, and Quantitative Sequencing of Cytosine Modifications
Working paper
Liu Y. et al, (2018)